CHIDOZIE AGU, M.D.
Pulmonary Disease Physician in ALBUQUERQUE, New Mexico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CHIDOZIE AGU, M.D. reported a CMS MIPS final score of 83.8451/100 — above the 83.1 national average — and filed 2,359 Medicare Part D claims in 2023.
- 83.8451/100
- MIPS score · +1 vs avg
- 2K
- Part D claims, 2023
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CHIDOZIE AGU, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
84 42nd percentile higher than 42% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
CHIDOZIE AGU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CHIDOZIE AGU, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Pulmonary Disease Physician compares to other specialties among New Mexico providers
Pulmonary Disease Physician share within New Mexico
Pulmonary Disease Physician is one of the more visible NUCC categories in New Mexico
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
CHIDOZIE AGU, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 83.8451/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) — 83.8451/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pulmonary Disease Physician US NPIs
83.8451/100 MIPS final score — 0.7 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pulmonary Disease Physician. Quality dim: 84.5974. Cost dim: 58.6394.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CHIDOZIE AGU, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 1100 CENTRAL AVE SE, ALBUQUERQUE, NM, 87106, with a listed phone of (505) 841-1430. NPI 1982952156 was issued on 08/20/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AGU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,359 prescription claims written by this provider, covering 363 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 61% brand-name and 39% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.8451/100 for the 2023 performance year (Quality 84.5974, Cost 58.6394), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1982952156 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/20/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CHIDOZIE AGU, M.D.'s current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where CHIDOZIE AGU, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Brand-heavy
61% brand-name claims vs 39% generic, on 2,359 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,320
- Total Day Supply
- 92,515
- Brand vs Generic
- 61% brand / 39% generic
- Brand Drug Cost
- $942K
- Generic Drug Cost
- $123K
- Antibiotic Claims
- 87
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.68
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 41, 65-74: 152, 75-84: 135, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CHIDOZIE AGU, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
266 claims
- Trelegy Ellipta
Trelegy Ellipta
229 claims
- Prednisone
Prednisone
195 claims
- Symbicort
Symbicort
191 claims
- Spiriva Respimat
Spiriva Respimat
175 claims
- Anoro Ellipta
Anoro Ellipta
143 claims
- Stiolto Respimat
Stiolto Respimat
134 claims
- Montelukast Sodium
Montelukast Sodium
115 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 266 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 229 |
| Prednisone | 195 |
| Symbicort Budesonide/Formoterol Fumarate | 191 |
| Spiriva Respimat Tiotropium Bromide | 175 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 143 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 134 |
| Montelukast Sodium | 115 |
| Flovent Hfa Fluticasone Propionate | 72 |
| Fluticasone Propionate | 56 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How CHIDOZIE AGU, M.D. fits within the Pulmonary Disease Physician landscape nationally.
CHIDOZIE AGU, M.D.'s 2,359 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as AGU.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Mexico
Frequently Asked Questions
What is CHIDOZIE AGU, M.D.'s specialty? ▼
How much does CHIDOZIE AGU, M.D. prescribe under Medicare Part D? ▼
What is CHIDOZIE AGU, M.D.'s Medicare quality score? ▼
Where is CHIDOZIE AGU, M.D. located? ▼
What is CHIDOZIE AGU, M.D.'s NPI number? ▼
Does CHIDOZIE AGU, M.D. prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does CHIDOZIE AGU, M.D. prescribe most often? ▼
Does CHIDOZIE AGU, M.D. accept Medicare? ▼
How can I verify CHIDOZIE AGU, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology